111 related articles for article (PubMed ID: 3109437)
1. In vitro inhibition of rat brain protein kinase C by rhodamine 6G. Profound effects of the lipid cofactor on the inhibition of the enzyme.
O'Brian CA; Weinstein IB
Biochem Pharmacol; 1987 Apr; 36(8):1231-5. PubMed ID: 3109437
[TBL] [Abstract][Full Text] [Related]
2. Potencies of protein kinase C inhibitors are dependent on the activators used to stimulate the enzyme.
Robinson PJ
Biochem Pharmacol; 1992 Oct; 44(7):1325-34. PubMed ID: 1417956
[TBL] [Abstract][Full Text] [Related]
3. Rhodamine 6G, inhibitor of both H+-ejections from mitochondria energized with ATP and with respiratory substrates.
Higuti T; Niimi S; Saito R; Nakasima S; Ohe T; Tani I; Yoshimura T
Biochim Biophys Acta; 1980 Dec; 593(2):463-7. PubMed ID: 7236646
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of protein kinase C by ether-linked lipids is not correlated with their antineoplastic activity on WEHI-3B and R6X-B15 cells.
Salari H; Dryden P; Davenport R; Howard S; Jones K; Bittman R
Biochim Biophys Acta; 1992 Feb; 1134(1):81-8. PubMed ID: 1543759
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol preferentially inhibits protein kinase C-catalyzed phosphorylation of a cofactor-independent, arginine-rich protein substrate by a novel mechanism.
Stewart JR; Ward NE; Ioannides CG; O'Brian CA
Biochemistry; 1999 Oct; 38(40):13244-51. PubMed ID: 10529197
[TBL] [Abstract][Full Text] [Related]
6. Import and processing of cytochrome b-c1 complex subunits in isolated hepatoma ascites cells. Inhibition by Rhodamine 6G.
Kolarov J; Nelson BD
Eur J Biochem; 1984 Oct; 144(2):387-92. PubMed ID: 6092071
[TBL] [Abstract][Full Text] [Related]
7. The bile acid analog fusidic acid can replace phosphatidylserine in the activation of protein kinase C by 12-O-tetradecanoylphorbol-13-acetate in vitro.
Ward NE; O'Brian CA
Carcinogenesis; 1988 Aug; 9(8):1451-4. PubMed ID: 3402041
[TBL] [Abstract][Full Text] [Related]
8. Bryostatin 1, an activator of protein kinase C, mimics as well as inhibits biological effects of the phorbol ester TPA in vivo and in vitro.
Gschwendt M; Fürstenberger G; Rose-John S; Rogers M; Kittstein W; Pettit GR; Herald CL; Marks F
Carcinogenesis; 1988 Apr; 9(4):555-62. PubMed ID: 2451575
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of arachidonic-acid-mediated brain protein kinase C activation: evidence for concentration-dependent heterogeneity.
Huang XP; Da Silva C; Fan XT; Castagna M
Biochim Biophys Acta; 1993 Feb; 1175(3):351-6. PubMed ID: 8435449
[TBL] [Abstract][Full Text] [Related]
10. Role of protein kinase C in the regulation of prostaglandin synthesis in human endothelium.
Garcia JG; Stasek J; Natarajan V; Patterson CE; Dominguez J
Am J Respir Cell Mol Biol; 1992 Mar; 6(3):315-25. PubMed ID: 1540395
[TBL] [Abstract][Full Text] [Related]
11. Role of Ca2+/phospholipid-dependent protein kinase in catecholamine secretion from bovine adrenal medullary chromaffin cells.
Tachikawa E; Takahashi S; Kashimoto T; Kondo Y
Biochem Pharmacol; 1990 Oct; 40(7):1505-13. PubMed ID: 2121147
[TBL] [Abstract][Full Text] [Related]
12. The regulation of protein kinase C by chenodeoxycholate, deoxycholate and several structurally related bile acids.
Fitzer CJ; O'Brian CA; Guillem JG; Weinstein IB
Carcinogenesis; 1987 Feb; 8(2):217-20. PubMed ID: 3802403
[TBL] [Abstract][Full Text] [Related]
13. Low concentrations of Rhodamine-6G selectively destroy tumor cells and improve survival of melanoma transplanted mice.
Kutushov M; Gorelik O
Neoplasma; 2013; 60(3):262-73. PubMed ID: 23373995
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of in vitro growth of Plasmodium falciparum by a brief exposure to the cationic rhodamine dyes.
Izumo A; Tanabe K
Ann Trop Med Parasitol; 1986 Jun; 80(3):299-305. PubMed ID: 3541806
[TBL] [Abstract][Full Text] [Related]
15. Relevance of the chemical charge of rhodamine dyes to multiple drug resistance.
Lampidis TJ; Castello C; del Giglio A; Pressman BC; Viallet P; Trevorrow KW; Valet GK; Tapiero H; Savaraj N
Biochem Pharmacol; 1989 Dec; 38(23):4267-71. PubMed ID: 2597199
[TBL] [Abstract][Full Text] [Related]
16. Rhodamine 6G inhibits the matrix-catalyzed processing of precursors of rat-liver mitochondrial proteins.
Kuzela S; Joste V; Nelson BD
Eur J Biochem; 1986 Feb; 154(3):553-7. PubMed ID: 2868895
[TBL] [Abstract][Full Text] [Related]
17. Activation of protein kinase C inhibits ATP-induced [Ca2+]i elevation in rat osteoblastic cells: selective effects on P2Y and P2U signaling pathways.
Gallinaro BJ; Reimer WJ; Dixon SJ
J Cell Physiol; 1995 Mar; 162(3):305-14. PubMed ID: 7860638
[TBL] [Abstract][Full Text] [Related]
18. Cobra venom cardiotoxin (cytotoxin) isoforms and neurotoxin: comparative potency of protein kinase C inhibition and cancer cell cytotoxicity and modes of enzyme inhibition.
Chiou SH; Raynor RL; Zheng B; Chambers TC; Kuo JF
Biochemistry; 1993 Mar; 32(8):2062-7. PubMed ID: 8448165
[TBL] [Abstract][Full Text] [Related]
19. Synergistic release of arachidonic acid from platelets by activators of protein kinase C and Ca2+ ionophores. Evidence for the role of protein phosphorylation in the activation of phospholipase A2 and independence from the Na+/H+ exchanger.
Halenda SP; Banga HS; Zavoico GB; Lau LF; Feinstein MB
Biochemistry; 1989 Sep; 28(18):7356-63. PubMed ID: 2554968
[TBL] [Abstract][Full Text] [Related]
20. ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha.
Daniel LW; Civoli F; Rogers MA; Smitherman PK; Raju PA; Roederer M
Cancer Res; 1995 Nov; 55(21):4844-9. PubMed ID: 7585518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
